Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeJ&J Innovative Medicine Research & Development

      J&J Innovative Medicine Research & Development

      “I couldn’t speak, walk or sit.” Inside a rare autoimmune disease that attacks the muscles

      Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. For Myositis Awareness Month, she shares her story.

      What it’s like when your baby has a rare blood disorder

      A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.

      Could we be on the cusp of catching Alzheimer’s before it starts?

      The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.

      9 Johnson & Johnson innovations that helped drive medicine forward

      From a superior way to sterilize surgical products to lifesaving medicine to treat a drug-resistant disease, check out just some of the ways Johnson & Johnson has exemplified innovation—and shared its breakthroughs with the world.

      5 things we now know about myasthenia gravis

      For Myasthenia Gravis Awareness Month, discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.

      How Johnson & Johnson is advancing new options for bladder cancer treatment

      Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.

      By the numbers: Understanding the toll of inflammatory bowel disease

      For Colitis and Crohn’s Disease Awareness Week, learn about the challenges of this painful condition—and why Johnson & Johnson continues to seek new treatment options.

      “My battle with IBD has fueled my passion for helping patients like me”

      Sid Jain, a leader on the pharmaceutical R&D data science team at Johnson & Johnson, knows that new and better treatment options change lives. And being a Crohn’s disease patient himself has supercharged his mission to help revolutionize the research process.

      “My family and I volunteer on a floating hospital that delivers medical care”

      Lee-Anne James is a Janssen clinical research manager whose home base is Australia. That is, when she and her family aren’t donating their time to Mercy Ships to help treat people who lack access to lifesaving healthcare.

      How advances in HIV treatment could help young people living with HIV

      We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.